79404288 - CTGCT CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY

Information

• Trademark
• 79404288

• Source

• Serial Number

  79404288

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 16 - Paper, cardboard and goods made from these materials, not included in other classes
  • 25 - Clothing, footwear, headgear
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  April 30, 2024
  a year ago

• Transaction Date

  July 20, 2025
  3 months ago

• Status Date

  June 23, 2025
  3 months ago

• Location Date

  June 23, 2025
  3 months ago

• Status Code

  641

• Current Location

  TMEG LAW OFFICE 107

  Employee Name

  LEE,YATSYE ISADORA

• Attorney Docket Number

  067221-00136

  Attorney Name

  Jennifer Fraser

  Law Office Assigned Location Code

  L70

• Owners

  • Kemijski institut

Case File Statements

• GS0411: Education, namely, conferences, workshops, seminars, and online courses in the field of gene and cell therapy, advanced therapy medicinal products (ATMPs), and translational medicine and distribution of course material in connection therewith; publication of texts, news reporting services in the field of gene and cell therapy, ATMPs, and translational medicine, and writing of texts, namely, writing of articles for professional journals other than for advertising or publicity; audio, video, and multimedia production, as well as photography; educational and teaching services, namely, workshops, seminars, conferences, online courses, and hands-on training in the field of gene and cell therapy, ATMPs, and translational medicine; organizing conferences, exhibitions, and competitions in the field of gene and cell therapy, ATMPs, and translational medicine; education, namely, conferences, workshops, seminars, and online courses in the field of gene and cell therapy technology; education, namely, workshops, seminars, and training programs in the treatment of diseases and cancer
• DM0000: The mark consists of two adjacent, slightly offset quadrilaterals outlined in blue, displaying the letters "CTGCT" in blue upon a white background, all of which appears above the wording "CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY" in blue.
• GS0091: Scientific, research, teaching and detecting apparatus and instruments, namely, microscopes, confocal laser microscopes, flow cytometers, bioreactors, cell sorters, and analytical systems; downloadable computer software for analyzing biological data, designing gene and cell therapies, and managing laboratory processes in the field of gene and cell therapy; scientific apparatus and instruments, namely, microscopes, confocal laser microscopes, flow cytometers, and bioreactors, and downloadable computer software for analyzing cell populations, designing viral vectors, and optimizing bioreactor processes used in gene and cell therapy technologies; scientific apparatus and instruments, namely, high-throughput confocal microscopes for kinetics measurements and in vivo imaging systems for live animal imaging in gene and cell therapy research, and downloadable computer software for analyzing genetic sequences and modeling drug responses used in the treatment of diseases and cancer; Pre-recorded USB flash drives featuring educational content on gene and cell therapy technologies and their applications in treating diseases and cancer
• GS0051: Pharmaceuticals and medical preparations for the treatment of genetic diseases, neurodevelopmental diseases and cancers; Diagnostic preparations for medical purposes; cells for medical use; pharmaceutical and medical preparations used in gene and cell therapy technologies; pharmaceutical compounds, preparations, and medicines used in the treatment of genetic diseases, neurodevelopmental diseases, and cancers; pharmaceutical compounds, preparations, and medicines used in the treatment of genetic, diseases and cancer
• GS0161: Printed matter, namely, printed brochures, reports, and educational materials in the field of gene and cell therapy, advanced therapy medicinal products (ATMPs), and translational medicine; bookbinding tape; printed photographs; stationery and office requisites, namely, printed notepads; printed notebooks; printed journals related to gene and cell therapy technology; printed informational flyers related to the treatment of diseases and cancer
• GS0251: Clothing, namely, lab coats, pants, shirts, t-shirts and headwear
• CC0000: The colors blue and white are claimed as a feature of the mark.
• GS0011: Chemicals for use in science; Chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical materials, namely assays, reagents, and nucleic acids for use in gene and cell therapy research; Chemical preparations for scientific purposes; natural fertilisers; chemical products used in gene and cell therapy technologies, namely viral vectors, plasmids, and lipid nanoparticles for gene delivery; active chemical ingredients used in the manufacture of medicines for diseases and cancer
• DS0000: "CENTRE FOR THE TECHNOLOGIES OF GENE AND CELL THERAPY"
• GS0101: Surgical and medical apparatus and instruments for use in gene therapy and cell therapy; surgical and medical apparatus and instruments used during medical and surgical procedures; medical apparatus and instruments, namely, bioreactors, cell sorters, flow cytometers, and analytical systems used in gene and cell therapy technologies; medical devices used in the treatment of genetic diseases and cancers
• GS0421: Scientific and technological services, namely, research and design in the fields of treatments for genetic diseases, neurodevelopmental diseases and cancers, and gene and cell therapy technology; industrial analysis, industrial research and industrial design services in the fields of treatments for genetic diseases, neurodevelopmental diseases and cancers, and gene and cell therapy technology; quality control and authentication services in the field of gene and cell therapy products; design and development of computer hardware and software; scientific laboratory services; biological and medical research laboratory services; laboratory services, namely, rental of laboratory apparatus and instruments; Research laboratory analysis services in the field of gene therapy, cell therapy, and synthetic biology; biological research, clinical research in the field of gene therapy and cell therapy for genetic diseases, neurodevelopmental diseases and difficult-to-treat cancers, and medical research; design and development of medical technology; development of new technologies for others; design and development of gene and cell therapy technology; scientific research for medical purposes in the field of diseases and cancer

Case File Event Statements

• 9/12/2024 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 9/16/2024 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/16/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/14/2024 - 11 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 11/15/2024 - 11 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/2/2024 - 10 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 11/16/2024 - 11 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/2/2024 - 10 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/21/2024 - 10 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 5/13/2025 - 5 months ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/13/2025 - 5 months ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/13/2025 - 5 months ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 7/19/2025 - 3 months ago

  14 - REFUSAL PROCESSED BY IB Type: RFNP

• 6/23/2025 - 3 months ago

  13 - NON-FINAL ACTION WRITTEN Type: CNRT